Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02816437Phase 1Withdrawn
Phase 1, open-label, single-arm trial of fecal microbiome transplant in organism colonization, sponsored by University of Miami. Primary endpoint: Number of participants with adverse events at 10 months. Planned start Jul 2016; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02816437.